Protective vascular treatment of patients with peripheral arterial disease: Guideline adherence according to year, age and gender

Canadian Journal of Public Health

Volumn 101, Issue 1, 2010, Pages 96-100

  Pâquet, Mariane ^a,b   Pilon, Danielle ^a,c   Tétrault, Jean Pierre ^c   Carrier, Nathalie ^d  

^a UNIVERSITY INSTITUTE OF GERIATRICS OF SHERBROOKE   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c UNIVERSITÉ DE SHERBROOKE   (Canada)

^d Centre Hospitalier Universitaire de Sherbrooke   (Canada)

Author keywords

Guideline adherence; Peripheral arterial disease; Secondary prevention

Indexed keywords

EID: 77950160420     PISSN: 00084263     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03405572     Document Type: Article

References (45)

1. Expert Panel on Detection EaToHBCiA. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III).[see comment]. JAMA 2001;285(19):2486-2497
2. Hiatt WR. Medical treatment of peripheral arterial disease and claudication. N Engl J Med 2001;344(21):1608-1621
3. Criqui MH, Denenberg JO, Langer RD, Fronek A. The epidemiology of peripheral arterial disease: Importance of identifying the population at risk. Vascular Med 1997;2(3):221-226
4. Higgins JP, Higgins JA. Epidemiology of peripheral arterial disease in women. J Epidemiol 2003;13(1):1-14.
5. Sigvant B, Wiberg-Hedman K, Bergqvist D, Rolandsson O, Andersson B, Persson E, et al. A population-based study of peripheral arterial disease prevalence with special focus on critical limb ischemia and sex differences. J Vascular Surgery 2007;45(6):1185-1191
6. Selvin E, Erlinger TP. Prevalence of and risk factors for peripheral arterial disease in the United States: Results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation 2004;110(6):738-743
7. Zheng ZJ, Rosamond WD, Chambless LE, Nieto FJ, Barnes RW, Hutchinson RG, et al. Lower extremity arterial disease assessed by ankle-brachial index in a middle-aged population of African Americans and whites: The Atherosclerosis Risk in Communities (ARIC) Study. Am J Prev Med 2005;29(5 Suppl 1):42-49.
8. Sritara P, Sritara C, Woodward M, Wangsuphachart S, Barzi F, Hengprasith B, et al. Prevalence and risk factors of peripheral arterial disease in a selected Thai population. Angiology 2007;58(5):572-578
9. Hiatt WR, Regensteiner JG, Hargarten ME, Wolfel EE, Brass EP. Benefit of exercise conditioning for patients with peripheral arterial disease. Circulation 1990;81(2):602-609
10. Smith GD, Shipley MJ, Rose G. Intermittent claudication, heart disease risk factors, and mortality. The Whitehall Study.[see comment]. Circulation 1990;82(6):1925-1931
11. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators.[ see comment][erratum appears in 2000;342(18):1376]. N Engl J Med 2000;342(3):145-153
12. Dormandy JA, Rutherford RB. Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Concensus (TASC). J Vascular Surgery 2000;31(1 Pt 2):S1-S296.
13. Criqui MH, Langer RD, Fronek A, Feigelson HS, Klauber MR, McCann TJ, et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 1992;326(6):381-386
14. Abramson BL, Huckell V, Anand S, Forbes T, Gupta A, Harris K, et al. Canadian Cardiovascular Society Consensus Conference: Peripheral arterial disease - Executive summary. Can J Cardiology 2005;21(12):997-1006.
15. Anonymous. Collaborative overview of randomised trials of antiplatelet therapy- I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration.[see comment][erratum appears in BMJ 1994;308(6943):1540]. BMJ 1994;308(6921):81-106.
16. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: A randomised placebo-controlled trial.[see comment][summary for patients in Curr Cardiol Rep 2002;4(6):486-87; PMID: 12379169]. Lancet 2002;360(9326):7-22.
17. Yusuf S. Two decades of progress in preventing vascular disease.[see comment][ comment]. Lancet 2002;360(9326):2-3.
18. Bhatt DL, Steg PG, Ohman EM, Hirsch AT, Ikeda Y, Mas JL, et al. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA 2006;295(2):180-189
19. Dunkley A, Stone M, Sayers R, Farooqi A, Khunti K. A cross sectional survey of secondary prevention measures in patients with peripheral arterial disease in primary care. Postgraduate Med J 2007;83(983):602-605
20. Hirsch AT, Criqui MH, Treat-Jacobson D, Regensteiner JG, Creager MA, Olin JW, et al. Peripheral arterial disease detection, awareness, and treatment in primary care.[see comment]. JAMA 2001;286(11):1317-1324
21. McDermott MM, Hahn EA, Greenland P, Cella D, Ockene JK, Brogan D, et al. Atherosclerotic risk factor reduction in peripheral arterial disease: Results of a national physician survey. J Gen Intern Med 2002;17(12):895-904.
22. McDermott MM, Mehta S, Ahn H, Greenland P. Atherosclerotic risk factors are less intensively treated in patients with peripheral arterial disease than in patients with coronary artery disease. J Gen Intern Med 1997;12(4):209-215
23. Steingart RM, Packer M, Hamm P, Coglianese ME, Gersh B, Geltman EM, et al. Sex differences in the management of coronary artery disease. Survival and Ventricular Enlargement Investigators.[see comment]. N Engl J Med 1991;325(4):226-230
24. Williams MA, Fleg JL, Ades PA, Chaitman BR, Miller NH, Mohiuddin SM, et al. Secondary prevention of coronary heart disease in the elderly (with emphasis on patients > or =75 years of age): An American Heart Association scientific statement from the Council on Clinical Cardiology Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention. Circulation 2002;105(14):1735-1743
25. Bowling A. Ageism in cardiology.[see comment]. BMJ 1999;319(7221):1353- 1355
26. Birkhead JS, Weston C, Lowe D. Impact of specialty of admitting physician and type of hospital on care and outcome for myocardial infarction in England and Wales during 2004-5: Observational study. BMJ 2006;332(7553):1306-1311
27. Shepherd J, Blauw GJ, Murphy MB, Bollen EL, Buckley BM, Cobbe SM, et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): A randomised controlled trial.[see comment]. Lancet 2002;360(9346):1623-1630
28. Simpson CR, Hannaford PC, Williams D. Evidence for inequalities in the management of coronary heart disease in Scotland. Heart 2005;91(5):630-634
29. Lee HY, Cooke CE, Robertson TA. Use of secondary prevention drug therapy in patients with acute coronary syndrome after hospital discharge.[see comment]. J Managed Care Pharmacy 2008;14(3):271-280
30. Williams D, Bennett K, Feely J. Evidence for an age and gender bias in the secondary prevention of ischaemic heart disease in primary care. Br J Clin Pharmacol 2003;55(6):604-608
31. Cournot M, Cambou JP, Quentzel S, Danchin N. Motifs de sous-utilisation des thérapeutiques de prévention secondaire chez les coronariens de plus de 70 ans. Annales de Cardiologie et d'Angeiologie 2005;54(Suppl 1):S17-S23.
32. Aronow WS. Treatment of older persons with hypercholesterolemia with and without cardiovascular disease. J Gerontology Series A-Biological Sciences & Medical Sciences 2001;56(3):M138-M145.
33. Majumdar SR, Gurwitz JH, Soumerai SB. Undertreatment of hyperlipidemia in the secondary prevention of coronary artery disease.[see comment]. J Gen Intern Med 1999;14(12):711-717
34. Crilly M, Bundred P, Hu X, Leckey L, Johnstone F. Gender differences in the clinical management of patients with angina pectoris: A cross-sectional survey in primary care. BMC Health Serv Res 2007;7:142.
35. Crilly MA, Bundred PE, Leckey LC, Johnstone FC. Gender bias in the clinical management of women with angina: Another look at the Yentl syndrome. J Women's Health 2008;17(3):331-342
36. Cho L, Hoogwerf B, Huang J, Brennan DM, Hazen SL. Gender differences in utilization of effective cardiovascular secondary prevention: A Cleveland clinic prevention database study. J Women's Health 2008;17(4):515-521
37. Keyhani S, Scobie JV, Hebert PL, McLaughlin MA. Gender disparities in blood pressure control and cardiovascular care in a national sample of ambulatory care visits.[see comment]. Hypertension 2008;51(4):1149-1155
38. Simpson CR, Wilson C, Hannaford PC, Williams D. Evidence for age and sex differences in the secondary prevention of stroke in Scottish primary care. Stroke 2005;36(8):1771-1775
39. Holroyd-Leduc JM, Kapral MK, Austin PC, Tu JV. Sex differences and similarities in the management and outcome of stroke patients. Stroke 2000;31(8):1833-1837
40. Kaplan RC, Tirschwell DL, Longstreth WT, Jr., Manolio TA, Heckbert SR, Lefkowitz D, et al. Vascular events, mortality, and preventive therapy following ischemic stroke in the elderly.[see comment][erratum appears in Neurology 2006;66(4):493]. Neurology 2005;65(6):835-842
41. Tamblyn R, Lavoie G, Petrella L, Monette J. The use of prescription claims databases in pharmacoepidemiological research: The accuracy and comprehensiveness of the prescription claims database in Quebec. J Clin Epidemiol 1995;48(8):999-1009.
42. Sigvant B, Wiberg-Hedman K, Bergqvist D, Rolandsson O, Wahlberg E. Risk factor profiles and use of cardiovascular drug prevention in women and men with peripheral arterial disease. Eur J Cardiovascular Prevention & Rehabilitation 2009;16(1):39-46.
43. Statistics Canada. Age Groups and Sex for Population of Canada (2006 Census). 2006. Accessed July 22, 2007.
44. Hobi A, Roy S, Vuille C, Perdrix J, Darioli R. Évolution du contr̂le des facteurs de risque cardiovasculaire chez les patients coronariens de plus de 65 ans. Rev Médicale Suisse 2006;2(56):658-663
45. Lovell M, Harris K, Forbes T, Twillman G, Abramson B, Criqui MH, et al. Peripheral arterial disease: Lack of awareness in Canada. Can J Cardiol 2009;25(1):39-45.